close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar4818Point98
Implied share price

Buy Undervalued by 127386.2%

5% margin of safety What's this?

EV / EBITDA
Use Average
PHST
OJSC Pharmstandard
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
9.92 -1.63 12.21 4.95 17.08 5.09
All amounts in millions
from last financial year
         
Implied Share Price $4818.98 $141.23 $169.44 $56.52 $80.16
Market Cap 592 130,102 107,921 100,042 98,744
Net Debt -23,664 47 7,450 -3,369 7,330
Enterprise Value (EV) -23,533 130,149 115,371 96,673 56,725
Revenue 47,194 21,662 32,639 13,418 34,861
EBITDA 14,420 10,657 23,287 5,661 11,136
Percent 30.6 % 49.2 % 71.3 % 42.2 % 31.9 %
EBIT 13,321 8,530 22,189 5,069 7,186
Percent 28.2 % 39.4 % 68.0 % 37.8 % 20.6 %
Balance Sheet          
Total Assets 82,621 71,449 51,716 21,787 102,321
Total Liabilities 28,957 43,366 33,182 6,116 44,272
Shareholders Equity 53,663 28,083 18,534 15,671 58,049.0

Comments

No comments yet. Login to comment.